WILMINGTON, DE — Incyte (Nasdaq: INCY) will present at two healthcare investor conferences in May as biotechnology companies continue using industry events to update investors on pipeline development, commercialization efforts, and capital allocation priorities.
The company announced it will participate in the BofA Securities 2026 Health Care Conference on May 13 and the RBC 2026 Global Healthcare Conference on May 19.
The presentations are scheduled for 1:40 p.m. PDT and 10:30 a.m. EDT, respectively.
Live webcasts and archived replays will be available for 30 days through Incyte’s investor relations website at Investor.Incyte.com.
Incyte develops treatments focused on hematology, oncology, inflammation, and autoimmune diseases.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.